[en] Sorption of U(VI) from aqueous solution to decarbonated calcareous soil (DCS) was studied under ambient conditions using batch technique. Soil samples were characterized by XRD, FT-IR and SEM in detail and the effects of pH, solid-to-liquid ratio (m/V), temperature, contact time, fulvic acid (FA), CO₂ and carbonates on U(VI) sorption to calcareous soil were also studied in detail using batch technique. The results from experimental techniques showed that sorption of U(VI) on DCS was significantly influenced by pH values of the aqueous phase, indicating a formation of inner-sphere complexes at solid-liquid interface, and increased with increasing temperature, suggesting the sorption process was endothermic and spontaneous. Compared to Freundlich model, sorption of U(VI) to DCS was simulated better with Langmuir model. The sorption equilibrium could be quickly achieved within 5 h, and sorption results fitted pseudo-second-order model well. The presence of FA in sorption system enhanced U(VI) sorption at low pH and reduced U(VI) sorption at high pH values. In absence of FA, the sorption of U(VI) onto DCS was an irreversible process, while the presence of FA reinforced the U(VI) desorption process reversible. The presence of CO₂ decreased U(VI) sorption largely at pH >8, which might due to a weakly adsorbable formation of Ca₂UO₂(CO₃)₃ complex in aqueous phase. (author)

[en] This work reports the synthesis and preliminary biodistribution results of [¹³¹I]SIB-PEG₄-CHC in tumor-bearing mice. The tributylstannyl precursor ATE-PEG₄-CHC was synthesized by conjugation of ATE to amino pegylated colchicine NH₂-PEG₄-CHC. [¹³¹I]SIB-PEG₄-CHC was radiosynthesized by electrophilic destannylation of the precursor with a yield of ∼44%. The radiochemical purity (RCP) appeared to be >95% by a Sep-Pak cartridge purification. [¹³¹I]SIB-PEG₄-CHC was lipophilic and was stable at room temperature. Biodistribution studies in tumor-bearing mice showed that [¹³¹I]SIB-PEG₄-CHC cleared from background rapidly, and didn't deiodinate in vivo. However, the poor tumor localization excluded it from further investigations as a tumor-targeted radiopharmaceuticals. (author)

[en] Amplification pretargeting strategies have great potential in nuclear medicine to increase the tumoral radioactivity concentration compared to conventional pretargeting. In this work, the dendrimer polyamidoamine generation 4 (PAMAM G4) was conjugated to multiple copies of peptide nucleic acid (PNA) as a signal amplification platform, which could combine with the antibody of CC49-cPNA and the tracer of ¹⁸F labeled complementary peptide nucleic acid (¹⁸F-cPNA) in biodistribution experiments to determine the signal amplification effect in vivo. The mice in the Amplification Group exhibited expected tumoral uptake (3.21 ± 0.77%ID/g), more than double that in the Pretargeting Group (1.21 ± 0.03%ID/g). Therefore, this work confirmed the signal amplification effect of dendrimer-PNA in vivo. (author)

[en] This work reports the synthesis, radiolabeling and preliminary biodistribution results in tumor-bearing mice of ^99mTc(CO)₃-labeled pegylated (PEG) 2-nitroimidazoles for tumor hypoxia imaging. The novel 2-nitroimidazole derivatives were successfully synthesized by conjugation of tridendate chelators to 2-nitroimidazole via PEG₃ linker. Radiolabeling was performed in high yield with [^99mTc(CO)₃]⁺ core to get cationic [^99mTc(CO)₃(BPA-PEG₃-NIM)]⁺, neutral [^99mTc(CO)₃(AOPA-PEG₃-NIM)] and anionic [^99mTc(CO)₃(IDA-PEG₃-NIM)]^- respectively, all of which were hydrophilic and stable at room temperature. Biodistribution studies in tumor-bearing mice showed that ^99mTc(CO)₃-labeled pegylated 2-nitroimidazoles accumulated in the tumor with low uptake. ^99mTc-chelate and charge had significant impact on partition coefficient, radiotracer tumor uptake and pharmacokinetic properties. The results indicate the need for synthetic modification of the parent 2-nitroimidazole derivatives and the ^99mTc-chelate with a view to improve the tumor targeting efficacy and in vivo kinetic profiles. (author)